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Protein–protein interactions (PPIs) play a key role in many, if not all, cellular processes.
Disease is often caused by perturbation of PPIs, as recently indicated by studies of
missense mutations. To understand the associations of proteins and to unravel the
global picture of PPIs in the cell, different experimental detection techniques for PPIs
have been established. Genetic and biochemical methods such as the yeast two-hybrid
system or affinity purification-based approaches are well suited to high-throughput,
proteome-wide screening and are mainly used to obtain qualitative results. However,
they have been criticized for not reflecting the cellular situation or the dynamic nature of
PPIs. In this review, we provide an overview of various genetic methods that go beyond
qualitative detection and allow quantitative measuring of PPIs in mammalian cells,
such as dual luminescence-based co-immunoprecipitation, Förster resonance energy
transfer or luminescence-based mammalian interactome mapping with bait control.
We discuss the strengths and weaknesses of different techniques and their potential
applications in biomedical research.
Keywords: PPI analysis, FRET, DULIP, FCCS, PLA, Interactome Mapping, BiFC, LUMIER, BRET, Quantification of
protein-protein interactions
INTRODUCTION
Physical interactions between proteins are crucial to most biological processes. Hence, major
efforts have been made to systematically identify protein–protein interactions (PPIs) using
the yeast two-hybrid (Y2H) system and affinity purification–mass spectrometry (AP/MS)
approaches (Stelzl et al., 2005; Yu et al., 2008; Guruharsha et al., 2011). However, these
methods are mainly suited for providing qualitative data, especially at the large scale. For a
more comprehensive functional description of interactions, additional information is required.
Knowledge of interaction strength, e.g., is of particular importance. It informs us of binding
affinities and lifetimes of protein complexes, which are critical for the dynamic regulation of
cellular systems (Perkins et al., 2010; Hieb et al., 2012). In summary, a better understanding
of complex cellular processes not only requires knowledge of which proteins interact but
also of the characteristics of interactions. To obtain such insight, quantitative experimental
techniques for the detection of PPIs in mammalian cells have moved into focus (Hieb et al.,
2012; Chen et al., 2015). These include biochemical methods such as quantitative affinity-
purification and mass spectrometry (qAP–MS; Hosp et al., 2015) or genetic methods such
as using luminescence-based mammalian interactome mapping with bait control (LUMIER
with BACON; Taipale et al., 2014). Using qAP–MS, e.g., the association of proteins with
neurodegenerative disease proteins such as amyloid precursor protein (APP), presenilin-1
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and ataxin-1 (ATXN-1) have been quantitatively analyzed and
the effects of disease-causing mutations on PPIs have been
systematically assessed in pull-down assays (Hosp et al., 2015).
The quantitative investigation of PPIs using LUMIER with
BACON revealed a comprehensive Hsp90–client interaction
network, which provided insight into previously unknown
organization principles of functional chaperone modules in
mammalian cells (Taipale et al., 2014).
A recent study suggests that about 60% of disease-causing
mutations in proteins influence their association with other
proteins. It was estimated that half of those mutations leads to
a complete loss of protein interactions while the other half only
perturbs a particular subset of interactions (Sahni et al., 2015).
A pathological poly-glutamine expansion in ATXN-1, causally
related to spinocerebellar ataxia type 1 (SCA1), e.g., was found to
induce binding of the protein to RBM17 rather than CiC, thereby
promoting disease (Lim et al., 2008). To detect such changes in
affinity and to map how interaction profiles of individual proteins
are changed through mutations, methods that allow quantitative
PPI analysis are urgently needed.
However, the available methodologies do not yet permit a
full quantitative assessment of PPIs at the cellular level. Current
methods to study binary PPIs in mammalian cells can broadly
be classified in two groups. Assays like bimolecular fluorescence
complementation (BiFC), bimolecular luminescence
complementation (BiLC) and proximity ligation assay (PLA)
yield a quantitative readout without allowing conclusions about
interaction strengths, while assays like Förster resonance energy
transfer (FRET), bioluminescence resonance energy transfer
(BRET), fluorescence cross-correlation spectroscopy (FCCS),
dual luminescence-based co-immunoprecipitation (DULIP) and
LUMIER with BACON provide a quantitative readout that can be
used to determine binding strengths. In this paper, we will review
recent developments in quantitative PPI detection technologies
and provide an overview of relevant applications of these
methods in biomedical research. We focus on genetic approaches
in mammalian cells, as mass spectrometry-based methods have
been recently reviewed elsewhere (Meyer and Selbach, 2015).
Protein microarrays also provide important insights on PPIs
and can provide quantitative readouts (MacBeath and Schreiber,
2000; Jones et al., 2006). They also have been reviewed elsewhere
and will not be discussed here (Wolf-Yadlin et al., 2009).
An overview of the discussed methods and their capabilities is
provided in Table 1.
FLUORESCENCE CROSS-CORRELATION
SPECTROSCOPY
Fluorescence correlation spectroscopy (FCS) was described for
the first time over 40 years ago (Magde et al., 1974; Machánˇ,
2014). It was developed to measure chemical reaction rates
and diffusion coefficients by analyzing the thermodynamic
fluctuations in the fluorescence intensity of a system. FCS is now
a well-established biophysical method, which in combination
with confocal microscopy is routinely used to obtain quantitative
information about the abundance of fluorescently tagged proteins TA
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in living cells (Machánˇ, 2014). Through the expansion of the
method to dual-color FCCS it became possible to quantify
interactions of labeled proteins in vivo under physiological
conditions (Schwille et al., 1997).
Fluorescence cross-correlation spectroscopy allows the
measurement of protein mobility, concentration and interactions
by exploiting the temporal fluorescence fluctuations of two
fluorescently labeled particles under a confocal laser scanning
microscope diffusing through a minute focal volume (Figure 1A).
As a distinct number of fluorescently labeled molecules diffuse
through the focal volume (Haustein, 2014), the fluorescence
signals fluctuate in a manner dependent on the mobility and
concentration of the investigated proteins. An autocorrelation
function of the fluctuating fluorescence signals provides
the diffusion coefficients and concentrations of molecules.
Importantly, FCCS utilizes two spectrally different fluorophores,
e. g., monomerized green or red fluorescent proteins, to label
a pair of proteins (Bacia et al., 2006). If the differently labeled
proteins are associated with each other, they pass through the
effective volume in a synchronized way. This causes simultaneous
fluctuation of their fluorescence signals leading to an increase
in the amplitude of the cross-correlation function, allowing the
determination of in vivo interaction strengths for proteins of
interest (Boeke et al., 2014). However, co-migration does not
fully prove a direct binary interaction of two-labeled molecules.
Thus, validation with other methods that are more stringent in
this regard is necessary (Shi et al., 2009).
Quantitative in vivo FCCS analysis, e.g., revealed binding
strengths for PPIs involved in the extracellular signal-regulated
kinase/mitogen-activated protein kinase (ERK/MAPK) pathway
(Sadaie et al., 2014). The generated quantitative data was utilized
to perform computer-assisted simulations to model the ERK-
/MAPK-signaling cascade, uncovering that Shc binding to EGFR
is critical for the regulation of the pathway. Similarly, systematic
FCCS studies of 41 PPIs revealed important information about
the regulation of clathrin-mediated endocytosis in yeast (Boeke
et al., 2014). Through the in vivo measurement of interaction
strengths for selected interactions likely to be involved in
endocytosis the protein Ede1 was discovered as a crucial scaffold
for the organization of this process. These results highlight the
application power of FCCS for quantitative detection of PPIs
in cells and show that quantitative PPI information improves
our current understanding of signal transduction pathways.
Through the systematic application of FCCS it seems feasible that
comprehensive, quantitative interactome maps can be generated
in the future.
BIMOLECULAR COMPLEMENTATION
METHODS: PROTEIN-FRAGMENT
COMPLEMENTATION ASSAY (PCA),
BiFC, AND BiLC
Protein-fragment complementation assays have been utilized
for a long time to detect PPIs in yeast or mammalian cells
(Johnsson and Varshavsky, 1994; Kerppola, 2006). PCAs are
classical reporter assays, in which a fluorescent protein or
enzyme, e.g., is split in two and the parts are then fused
to the N- or C-terminal end of the potential interactors. If
the proteins of interest interact, the fragments unite, emitting
measurable fluorescence or displaying quantifiable enzymatic
activity. Different PCA variants have been used successfully in
small- or proteome-scale applications to detect PPIs (Tarassov
et al., 2008; Sung et al., 2013; Petschnigg et al., 2014).
One of the most commonly used PCA variants is the BiFC
assay, which is based on the reconstitution of a fluorescent
protein such as the green fluorescent protein (GFP) (Kerppola,
2008; Kodama and Hu, 2012). In an application of BiFC,
an N-terminal GFP fragment (NGFP) containing the first
157 amino acids and a C-terminal GFP fragment (CGFP)
fragment containing 81 terminal amino acids were fused to
peptides that are known to assemble into antiparallel leucine
zippers (Ghosh et al., 2000). The interaction of the peptides
led to the reconstitution of functional GFP molecules that
exhibited a single excitation maximum at 475 nm and an
emission maximum at 506 nm. Today, multiple BiFC assays
with many different split fluorescent proteins (FPs) are available
for application, including ECFP, EGFP, EYFP (Figure 1B),
Venus, Citrine, Cerulean, or mCherry [reviewed in Miller
et al., 2015]. However, all PPI detection assays with split-
FP variants suffer from spontaneous self-assembly of the
utilized fragments, which results in relatively high background
fluorescence in cells. To overcome this limitation, variants of
the Venus-based BiFC PPI detection system with an improved
signal-to-noise ratio were developed (Kodama and Hu, 2010).
Another disadvantage of most if not all currently available
BiFC methods is that split–FP fusions form irreversible protein
complexes in vitro and in vivo, which can lead to false-positive
results. Also, they only allow measuring the association of
protein complexes but not their dissociation (Ciruela et al.,
2010).
A related PCA is the BiLC assay, which uses luciferases
rather than fluorescent proteins (Figure 1C). As for BiFC,
several variants of the method are available that utilize
different luciferases such as firefly (Paulmurugan et al., 2002),
Renilla (Paulmurugan and Gambhir, 2003), Gaussia (Remy and
Michnick, 2006), or NanoLuc R© (Dixon et al., 2015). Importantly,
the reconstitution of the luciferase fragments is reversible in
these assays, allowing the detection of both association and
dissociation of fusion proteins in living cells in real-time (Remy
and Michnick, 2006). Compared to BiFC, BiLC assays offer
a higher signal-to-noise ratio, which is very advantageous for
the large-scale detection of PPIs in cells. BiLC assays were
also utilized to study the localization of PPIs in cells (Kaihara
et al., 2003). However, due to the relatively low number of
emitted photons this can be a very challenging task (Kato,
2012).
The power of BiFC-based PPI detection methods lies in
their ability to identify weak or transient interactions in cells
(Miller et al., 2015). This is because fusion proteins are stabilized
in complementation assays and fluorescent signals are only
observed when the tagged fusions interact directly. The relatively
weak interaction between the SH3 domain of c-Abl and the
Frontiers in Genetics | www.frontiersin.org 3 May 2016 | Volume 7 | Article 74
fgene-07-00074 May 2, 2016 Time: 11:19 # 4
Buntru et al. Quantitative Protein–Protein-Interaction screening
FIGURE 1 | Overview of genetic protein–protein interaction (PPI) methods. (A) In Fluorescence cross-correlation spectroscopy (FCCS) measurements,
co-migration of two fluorescently labeled molecules through a focal volume is quantified. (B) bimolecular fluorescence complementation (BiFC) utilizes two
non-fluorescent fragments of EGFP or a variant. Upon interaction of the two labeled proteins, the fragments can reassociate, resulting in fluorescence. (C) The
principle of bimolecular luminescence complementation (BiLC) is similar to BiFC but is based on two fragments of a luciferase. In contrast to BiFC, the reassociation
is reversible. (D) Close proximity of two DNA oligomer-labeled antibodies allows circularization of two additional oligomers after hybridization. The product is
amplified in a rolling circle reaction and subsequently detected with fluorescently labeled probes. (E) During Förster resonance energy transfer (FRET), energy is
transferred non-radiatively from an excited donor molecule to an acceptor molecule. In case the acceptor is also a fluorophore, the transmitted energy is emitted at a
longer wavelength (the so called sensitized emission). (F) bioluminescence resonance energy transfer (BRET) is similar to FRET with the difference that a luciferase
serves as a donor molecule. (G) In dual luminescence-based co-immunoprecipitation (DULIP) assays, two proteins of interest are fused to firefly or Renilla luciferase,
respectively. An additional PA-tag allows precipitation of the bait protein from the lysate. If an interaction occurs, co-precipitation of the prey protein is indicated by
luminescence arising from the firefly luciferase.
poly-proline peptide p41 (Kd = 1.5 µM), e.g., could be readily
detected in intact cells using a YFP-based BiFC assay (Morell
et al., 2007). Recently, a recombinase enhanced bimolecular
luciferase complementation (ReBiL) platform was established
that allows the detection of low-affinity PPIs in living cells. It
enabled the discovery of the interaction between the E3 ubiquitin
ligase FANCL and the ubiquitin-conjugating enzyme UBE2T
(Kd = 0.454 µM), two key players in DNA repair processes (Li
et al., 2014).
BiFC and BiLC allow rapid, sensitive investigation of PPIs in
cells with a quantitative data output both in focused experiments
as well as on the proteome scale (Sung and Huh, 2010). To
assess binding affinities of interacting proteins in cells, however,
both unbound and bound protein molecules would need to
be quantified. This is not possible with BiFC or BiLC assays
because only interacting fusion proteins show fluorescence or
luminescence complementation (Figures 1B,C). Finally, it is
important to note that the lack of information on unbound
FPs in BiFC assays may lead to false positive as well as false
negative results in systematic PPI screenings, simply because the
expected bait and prey fusions may not be properly expressed in
cells.
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PROXIMITY LIGATION ASSAYS
The proximity ligation assay utilizes antibodies to which short
single-stranded DNA oligonucleotides, often termed PLA probes,
have been attached (Fredriksson et al., 2002; Söderberg et al.,
2006; Weibrecht et al., 2010). When bound to two proteins that
are in close proximity in biological systems (distance < 30 nm),
these antibody–DNA probes facilitate the ligation of additional
DNA molecules by ligases and subsequent amplification by
polymerase chain reaction or a rolling circle mechanism. The
amplified DNA molecules function as templates for the binding
of fluorescently labeled oligonucleotide probes that act as
surrogate markers for interacting proteins (Figure 1D). The dual
recognition by PLA probes required for the formation of DNA
reporter molecules decreases non-specific signals because only
ligated reporters are amplified (Weibrecht et al., 2010).
Proximity ligation assays have the advantage over methods
like BiFC or FCCS that associations between proteins can be
identified and quantified without additional tags. The only
requirement is the availability of specific, high-affinity antibodies
against the proteins of interest that can be modified with DNA
oligonucleotides. In the last 10 years, multiple variants of PLAs
have been developed, which can be applied to the detection of
protein–protein, protein–DNA, and protein–RNA interactions
(Swartzman et al., 2010; Hansen et al., 2014). Furthermore,
the method was adapted for the identification of interactions
dependent on post translational modifications. Recently, e.g.,
an SH2-PLA was established, which allows the quantification
of interactions between an SH2 domain and phosphotyrosines
in the EGFR using a microtiter plate format (Thompson et al.,
2015). This method, which is highly sensitive and has a large
dynamic range, has a wide array of applications both in basic and
translational cancer research. Similarly, an in situ PLA variant
was successfully applied to detect the Erα/Src/PI3K protein
complex in breast cancer cells and patient samples (Poulard et al.,
2014), suggesting that the method has the potential to be utilized
as diagnostic tool.
Although several studies have generated quantitative
information about PPIs using PLAs, e.g., through secondary
methods like color segmentation image analysis (Gajadhar
and Guha, 2010; Leuchowius et al., 2010; Pacchiana et al.,
2014), the currently available variants cannot be utilized
to define binding strengths of interactions. To obtain such
information, knowledge about the abundance of both bound
and unbound protein molecules would be required. However,
PLAs remain powerful tools to validate interactions initially
identified in high-throughput screens under physiological
conditions.
FRET-BASED METHODS
The fundamental theory of FRET was established in the first half
of the 20th century (Cario and Franck, 1922). Its great potential
for biological research, however, has only been realized in the
past 20 years, after different techniques had been developed that
allowed the application of FRET in biological systems (Mills
et al., 2003; Wallrabe and Periasamy, 2005; Ma et al., 2014).
This, in particular, includes the combination of FRET with
microscopy techniques, which allow the investigation of PPIs
with temporal and spatial resolution in vivo (Sun et al., 2013).
FRET is a distance-dependent process in which, through dipole–
dipole interactions, an exited fluorophore molecule (the donor)
transfers energy non-radiatively to another fluorophore molecule
(the acceptor), resulting in acceptor emission (Lakowicz, 2013).
Alternatively, dark quenchers can be used as acceptors for
studying, e.g., membrane–protein interactions (Cho et al., 2016).
There are three main conditions that need to be met for
efficient FRET: (i) there must be “spectral overlap” of the donor’s
emission and the acceptor’s excitation spectra, (ii) the donor
and acceptor fluorophores (termed FRET pair) must be in close
proximity and (iii) the dipoles of the donor and acceptor must
be aligned (Lakowicz, 2013). Due to the fact that FRET efficiency
is proportional to the inverse of the sixth power of the distance
between the donor and the acceptor, only fluorophores that are
in very close proximity (<10 nm) show FRET (Clegg, 1995).
Thus, FRET allows the detection of direct interactions between
proteins, whereas methods such as FCCS, PLA, DULIP, or
LUMIER with BACON cannot distinguish between proteins that
directly interact or are only present in the same complex (Li et al.,
2015).
To measure FRET with microscopic techniques several
basic approaches have been developed. This includes acceptor
photobleaching (Szabà et al., 1992), fluorescence life-time
imaging microscopy (Wallrabe and Periasamy, 2005), spectral
imaging (Chen, 2011), and sensitized emission, which still is
the most commonly applied FRET method. Sensitized emission
measurements can be performed using standard confocal and
wide-field microscopes with appropriate filters or fluorescence
microplate readers. Three channels are normally required for
the imaging of donor, acceptor and FRET signals. The sensitized
emission method, also called three-cube FRET, is based on
the detection of acceptor fluorescence after donor excitation
(Gordon et al., 1998; Mattheyses and Marcus, 2015). However,
it is important to note that usually it is not possible to visualize
sensitized emission directly due to contamination of the FRET
signal by both donor and direct acceptor fluorescence. Thus, the
measurement has to be corrected for donor bleed-through and
acceptor cross-excitation, which can be performed through the
calculation of calibration factors obtained from measurements
with reference samples containing either donor or acceptor
molecules alone (Mattheyses and Marcus, 2015). Currently,
various algorithms are available to correct for these fluorescence
contaminations, which all give comparable results (Zal and
Gascoigne, 2004; Chen et al., 2006). Subsequent normalization
to the donor or acceptor protein level (or a combination
of both) provides a quantitative FRET signal (Hoppe et al.,
2002; Zal and Gascoigne, 2004; Chen et al., 2006; Elder et al.,
2009).
To study PPIs with FRET, the proteins of interest need to be
tagged with appropriate donor and acceptor fluorophores. This
is possible through the production of genetically encoded fusions
with fluorescent protein tags in cells using multiple expression
plasmids (Hochreiter et al., 2015). This includes FRET pairs
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such as ECFP/EYFP (Figure 1E), mTurquoise/mCitrine
or EGFP/mCherry that are commonly applied for the
investigation of PPIs in cells (Day and Davidson, 2012;
Mattheyses and Marcus, 2015). A major strength of FRET-
based interaction studies in living cells is that quantitative
information about PPIs can be obtained. This is achieved
through saturation experiments in which FRET is monitored
in cells coexpressing a constant amount of donor-tagged
protein with increasing amounts of acceptor-tagged protein
or vice versa (Carriba et al., 2008; Martínez-Muñoz et al.,
2014). Through such an approach, FRET50 values can be
calculated, which provide an indication about the binding
strength of tagged interacting proteins. However, it needs
to be noted that FRET measurements in living cells can
provide information about binding affinities only when the
absolute concentrations of investigated proteins are known.
Such information, however, is generally not available without
additional measurements in standard FRET-based PPI studies
(Sun et al., 2013). Nevertheless, a recent study demonstrated
that reliable in vivo binding affinities between the proteins
glutathione (GSH) and glutathione-S-transferase (GST) can
be obtained from FRET measurements in intact cells (Chen
et al., 2015). Thus, FRET microscopy and spectroscopy are
powerful techniques that can provide highly reliable information
about the binding strengths of PPIs, even at subcellular
resolution.
BRET-BASED METHODS
Bioluminescence resonance energy transfer is a biophysical
technique that, similar to FRET, can be readily applied for
quantifying PPI strengths in living cells (Pfleger and Eidne, 2006).
One distinction between the two methods is that FRET involves
energy transfer between two fluorophores, one of which requires
extrinsic excitation by a suitable light source, whereas BRET
occurs after oxidation of a substrate (e.g., coelenterazine) through
a luciferase enzyme (Figure 1F). Previous studies indicate that
different luciferase enzymes such as Renilla luciferase (Rluc)
or NanoLuc in combination with various fluorophores (e.g.,
EYFP) are suitable for in-cell BRET experiments and for the
quantification of PPIs using BRET50 values (Hamdan et al.,
2006; Szalai et al., 2014; Brown et al., 2015). The assembly
of G protein-coupled receptors, e.g., was successfully studied
in mammalian cells with the help of BRET (Stoddart et al.,
2015). Furthermore, it was shown that a sequential BRET–
FRET technique (termed SRET) is able to detect the interactions
between three proteins in vivo (Carriba et al., 2008). Combined
BRET and FRET methods are powerful tools to analyze the
assembly of higher-order protein complexes and the effects of
posttranslational modifications on PPIs. Recently, a BRET–FRET
approach was applied to study the oligomerization of the proteins
CCR5, CD4 and CXCR4, which are of critical importance for
the infection of cells by HIV-1 (Martínez-Muñoz et al., 2014).
Thus, novel fluorescence and luminescence-based methods allow
the systematic quantitative analysis of protein complexes in cell
models. They might be advanced for routine validation of PPIs
identified in high-throughput screens with qualitative assays
(Rolland et al., 2014).
LUCIFERASE-BASED
CO-IMMUNOPRECIPITATION METHODS
Co-immunoprecipitation (Co-IP) is commonly used to detect
PPIs in protein extracts (Phizicky and Fields, 1995). However,
identifying interactions with Co-IPs is laborious and time
consuming, making the method unsuitable for systematic
screening. To overcome these limitations, a luminescence-based
Co-IP assay – termed LUMIER – was developed, which provides
at least semi-quantitative PPI information and can be performed
in microtiter plates (Barrios-Rodiles et al., 2005). Here, bait
and prey proteins are co-produced as FLAG and Renilla
fusions in mammalian cells and interactions are detected by
luciferase enzymatic assays in co-immunoprecipitates. LUMIER
has the advantage that large numbers of bait/prey pairs can be
systematically tested for putative interactions under relatively
well-defined assay conditions. The method was successfully
applied for the generation of a dynamic PPI network for the
TGF beta pathway (Barrios-Rodiles et al., 2005) as well as for
the identification of inhibitors of the Wnt pathway (Miller et al.,
2009), indicating that it is suitable for the elucidation of novel
signaling pathway components with high confidence.
The original LUMIER assay has the disadvantage that
the FLAG-tagged bait proteins cannot be quantified in co-
immunoprecipitates, which may lead to false negative results
in large-scale PPI screenings. To overcome this limitation, an
improved version of the LUMIER assay was recently established
(Taipale et al., 2012, 2014), which was termed LUMIER with bait
control (LUMIER with BACON). Here, the immunoprecipitated
FLAG-tagged bait proteins are systematically quantified by
ELISA. LUMIER with BACON, which can also be performed
in microtiter plates, facilitates the calculation of quantitative
interaction scores that can be used for hierarchical clustering
of PPIs and the prediction of potential functional modules.
Applying LUMIER with BACON, a quantitative chaperone
interaction network was generated that enabled the identification
of regulators of cellular proteostasis (Taipale et al., 2014).
A dual luciferase reporter pull-down (DLR-PD) assay for
the detection of PPIs in mammalian cells was also reported
(Jia et al., 2011). In this assay, bait and prey proteins are
co-produced in cells as firefly and Renilla luciferase fusions,
respectively. In addition, the expressed bait protein harbors a
HAVI-tag that is recognized and biotinylated by the co-produced
biotin-protein ligase BirA. The DLR-PD assay was shown to
successfully detect nuclear and cytoplasmic PPIs in HEK293
cell lysates, suggesting that the method can be applied for
PPI screening. However, pull-down assays with beads are not
easy to scale up for high-throughput applications. To overcome
this limitation, most recently a DULIP assay was developed
for interactome mapping in mammalian cells (Trepte et al.,
2015). This method can be performed in 384-well microtiter
plates and can be automated for large-scale interaction screens
(Figure 1G).
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In DULIP assays the bait and prey proteins are co-produced
as Renilla and firefly luciferase fusions in mammalian cells,
respectively. In addition, the expressed bait protein harbors a
protein A (PA) tag (Li, 2010) that allows the co-precipitation
of bait/prey complexes in microtiter plates. The successful
expression of bait and prey fusion proteins as well as the success
of bait/prey co-precipitation can be quantified using DULIP. This
enables the calculation of quantitative, normalized interaction
ratios for all tested protein pairs, which can be utilized to create
quantitative PPI interaction maps. The method, e.g., was capable
of detecting the effects of point mutations on the interaction
strength of synaptic proteins (Trepte et al., 2015), suggesting
that it might be suitable for more comprehensive investigations
of the effects of disease-causing mutations on PPIs. Taken
together, luminescence-based assays are powerful PPI detection
methods that, in the future, might allow us to obtain quantitative
information about interactions in large-scale systematic studies.
CONCLUSIONS AND OUTLOOK
Resulting from multiple high-throughput PPI screening efforts
with genetic and biochemical methods (Stelzl et al., 2005;
Yu et al., 2008; Rolland et al., 2014), we currently possess
large databases with unexplored interactions. Their further
characterization requires quantitative experimental strategies
that are easy to implement in laboratories and allow the
identification of interactions at medium to high throughput in
mammalian cells. Recent developments indicate that quantitative
PPI information can be generated in vivo with methods such
as FCCS, BRET, DULIP, or LUMIER with BACON (Table 1).
This opens new avenues for interactomics researchers because
the dynamics and strengths of PPIs can be assessed for the
first time with these techniques. Also computational approaches
to predict or filter PPIs relevant to a given question will
profit enormously from direct prioritization of PPIs based on
quantitative interaction data. It seems now possible to capture
a broad range of high-, medium- and low-affinity interactions
and to link this information to specific cellular processes. In
the long run, this will enable us to describe the molecular
principles of biological systems in more detail and to improve
our understanding of disease processes. We suggest that truly
quantitative interactome research is now within reach and efforts
need to be intensified to obtain comprehensive quantitative PPI
data sets in living cells.
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